New method could help to reconnect injured organs or build functional human tissues from the ground up
(BOSTON) — A team of researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard University has found a way to self-assemble complex structures out of bricks smaller than a grain of salt. The self-assembly method could help solve one of the major challenges in tissue engineering: regrowing human tissue by injecting tiny components into the body that then self-assemble into larger, intricately structured, biocompatible scaffolds at an injury site.
The key to self-assembly was developing the world’s first programmable glue. The glue is made of DNA, and it directs specific bricks of a water-filled gel to stick only to each other, the scientists report in the September 9th online issue of Nature Communications.
“By using DNA glue to guide gel bricks to self-assemble, we’re creating sophisticated programmable architecture,” says Peng Yin, Ph.D., a Core Faculty member at the Wyss Institute and senior coauthor of the study, who is also an Assistant Professor of Systems Biology at Harvard Medical School. This novel self-assembly method worked for gel bricks from as small as a speck of silt (30 microns diameter) to as large as a grain of sand (1 millimeter diameter), underscoring the method’s versatility.
The programmable DNA glue could also be used with other materials to create a variety of small, self-assembling devices, including lenses, reconfigurable microchips, and surgical glue that could knit together only the desired tissues, said Ali Khademhosseini, Ph.D., an Associate Faculty member at the Wyss Institute who is the other senior coauthor of the study.
“It could work for anything where you’d want a programmable glue to induce assembly of higher-order structures, with great control over their final architecture — and that’s very exciting,” said Khademhosseini, who is also an Associate Professor at Harvard-MIT’s Division of Health Sciences and Technology (HST), Brigham and Women’s Hospital, and Harvard Medical School.
To fabricate devices or their component parts, manufacturers often start with a single piece of material, then modify it until it has the desired properties. In other cases, they employ the same strategy as auto manufacturers, making components with the desired properties, then assembling them to produce the final device. Living organisms fabricate their tissues using a similar strategy, in which different types of cells assemble into functional building blocks that generate the appropriate tissue function. In the liver, for example, the functional building blocks are small tissue units called lobules. In muscle tissue, the functional building blocks are muscle fibers.
Scientists have tried to mimic this manufacturing strategy by developing self-assembling systems to fabricate devices. For example, last year Yin and his team reported in Science that they had developed miniscule “DNA bricks” smaller than the tiniest virus that self-assemble into complex nanoscale 3D structures.
Now, he and Khademhosseini sought to create a similar programmable, self-assembling system for mesoscale components — those with edge widths ranging from 30 microns to 1000 microns (1 millimeter). They focused first on creating a system in which bricks of biocompatible, biodegradable gels called hydrogels self-assemble into complex structures. For future applications, small hydrogel bricks containing human cells could potentially be injected into the body. The bricks would assemble, then the cells would knit together to form functional tissue as the hydrogels break down.
In previous attempts to self-assemble hydrogel bricks into complex structures, scientists faced a challenge: the bricks often glom onto one another rather than assembling into the desired architecture. Yin and Khademhosseini needed a way to help each component stick only to specific partners, but not to other components. In other words, they needed programmable glue.
The researchers used enzymes to multiply a snippet of DNA into long pieces of DNA called “giant DNA” that contained multiple copies of that snippet. When they coated hydrogel cubes with giant DNA, the cubes adhered only to partner cubes coated with matching giant DNA. Since scientists can synthesize snippets of DNA with any sequence they want, this meant that giant DNA functioned as programmable DNA glue.
To assemble hydrogel cubes into larger structures, they used smaller hydrogel cubes as connectors. They coated the connector cube with their DNA glue, then attached it to one of the six faces of a larger cube. A large cube outfitted this way adhered only to other large cubes whose connectors had matching DNA glue.
By placing connector cubes on various faces of the larger cubes, they programmed the larger cubes to self-assemble into specific shapes, including a matching pair of cubes, a linear chain, a square, and a T-shaped structure.
The method was so specific that when the researchers placed 25 pairs of matched cubes in a single pot, all the cubes located and adhered only to their partners. This ability to assemble multiple components simultaneously is called multiplexity, and the new system has the highest degree of multiplexity of all existing mesoscale self-assembly systems.
“Designing a strategy that leverages the power of self assembly used by living systems to direct construction of tissues from tiny component parts represents an entirely new approach for tissue engineering,” said Don Ingber, M.D., Ph.D., the Wyss Institute’s Founding Director. “Peng and Ali have created an elegant and straightforward method that could permit tissues to be reconstructed from within after a simple injection, rather than requiring major surgery.”
This work was funded by the National Institutes of Health, by the Office of Naval Research, by the National Science Foundation, and by the Wyss Institute. In addition to Yin and Khademhosseini, the research team included: Hao Qi, a postdoctoral fellow at the Wyss Institute; Majid Ghodousi, a research assistant at the Wyss Institute; Yanan Du, a former postdoctoral fellow at the Wyss Institute who is now a Professor of Biomedical Engineering at Tsinghua University in Beijing, China; Casey Grun, an undergraduate researcher at the Wyss Institute, and Hojae Bae, a former Instructor of Medicine at Harvard Medical School who is now an Assistant Professor of Bioindustrial Technologies at Konkuk University in South Korea.